A Study to Compare PK and Safety of CKD-381 and D026 in Healthy Male Subjects

NCT03444402 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

GERD

Interventions

DRUG: CKD-381(formulation I)
DRUG: CKD-381(formulation II)
DRUG: D026(Nexium 40mg)

Sponsor

Chong Kun Dang Pharmaceutical